New endoscopic, non-surgical bariatric options show promise for treating obesity

The FDA recently approved two new endoscopic bariatric therapies (EBT) for the treatment of obesity. According to the American Society for Gastrointestinal Endoscopy (ASGE), this development provides important new, minimally invasive tools for combatting the obesity epidemic and offers many patients an alternative to surgery.

Many new and emerging treatments can be performed endoscopically, providing an effective and minimally invasive approach that fills a gap in the management of obesity and related conditions.
Despite the positive impact of bariatric surgery on individual patients, only about 1 percent of qualified candidates undergo these surgical procedures.